Reimbursement News
Reimbursement news and insurance coverage updates.
Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests
Tests like MDxHealth's SelectMDx, Bio-Techne's ExoDx Prostate, and various PSA scoring algorithms would be reimbursed if they pass a technical assessment.
ESMO Advances Biomarker Framework to Guide Cancer Therapy De-Intensification, Decision-Making
Premium
The framework, which ranks de-intensification biomarkers by evidence tiers, could give oncologists, patients, regulators, and payors a common system to guide their use.
MNM Bioscience Wins $800K Eurostars Grant to Stratify Ovarian Cancer Patients
The bioinformatics startup will work with Macrogen Europe to develop an AI-based tool for analyzing WGS data to identify patients who should receive PARP inhibitors.
Medicare Contractor's Final Coverage Decision on NGS Cancer Testing Appeases Industry Stakeholders
Premium
The LCD covers tests that are FDA approved or cleared, have published analytical validity evidence, or are certified by a third party to be aligned with NYSDOH's criteria.Â
Expert Reviews of NGS Reports Helping Community Docs Clear 'Last Mile' Hurdle in Precision Oncology
Premium
Precision oncology experts and molecular tumor boards are helping community oncologists decipher NGS reports, reduce reimbursement headaches, and improve patients' outcomes.